Resumo

SAEZ-TORRES-DE VICENTE, M; FERRIS-VILLANUEVA, M; REDONDO-GALAN, C  e  RANGEL-MAYORAL, JF. Skin reaction due to remdesivir in a patient with SARS-CoV-2 disease. Rev. OFIL·ILAPHAR [online]. 2022, vol.32, n.3, pp.299-300.  Epub 25-Set-2023. ISSN 1699-714X.  https://dx.doi.org/10.4321/s1699-714x20220003000015.

In December 2019, a new infectious disease with the official name of COVID-19 was detected for the first time in the Chinese city of Wuhan, caused by a new type of coronavirus called SARS-CoV-2 virus, the infection has spread rapidly and widely throughout the world, which is why on March 11, 2020, the World Health Organization declared it a pandemic. As it is a new infection, there is currently no evidence to recommend a specific treatment, currently the only drug with an indication authorized by the European Medicines Agency (EMA) is remdesivir.

We present the case of an adverse reaction to remdesivir, although it was not serious, it is worth highlighting the importance of reporting adverse effects and more in novel drugs like this one.

Palavras-chave : COVID-19; adverse effect; remdesivir.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )